Topic 464 phase i award: network-based multimodal data analysis cloud software for cancer biomarker discovery and drug development
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91024C00082
- Awardee
-
Sostos Inc. UEI TW4LF32FLS31
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $400,000
Award facts
- Contract value 88% obligated
-
- $400,000.00 Current, with exercised options
- $455,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 15 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Everettville, WV 26505, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI) awarded a $455,000.00 Firm Fixed Price Definitive Contract to Sostos Inc., a minority-owned, woman-owned small disadvantaged business. This Phase I contract is a Small Business Set Aside to develop a network-based multimodal data analysis cloud software for cancer biomarker discovery and drug development. The project, titled "TOPIC 464 PHASE I AWARD: NETWORK-BASED MULTIMODAL DATA ANALYSIS CLOUD SOFTWARE FOR CANCER BIOMARKER DISCOVERY AND DRUG DEVELOPMENT," has a completion date of September 15, 2025. Sostos Inc. is an innovative small business with expertise in advanced biomedical technology and artificial intelligence solutions focused on cancer research and diagnostics. The contract award demonstrates the company's capability to create sophisticated computational tools that support cancer research methodologies utilizing cloud-based software and artificial intelligence technologies.
Quick answers
Who was awarded contract 75N91024C00082?
75N91024C00082 was awarded to Sostos Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2024.
How much is contract 75N91024C00082 worth?
The government has obligated $400,000 on 75N91024C00082. Its potential value, with all options, is $455,000.
Was contract 75N91024C00082 competed?
The extent of competition for 75N91024C00082 was full and open competition after exclusion of sources. The government received 15 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award